Dermatol. praxi. 2023;17(2):94-96 | DOI: 10.36290/der.2023.016

Clinical improvement in a patient with lichen planopilaris

MUDr. Nadezhda Vidolova Brabcová
Klinika preventivní dermatologie s. r. o., Praha

Lichen planopilaris (LPP) is an inflammatory, primary cicatricial alopecia where hair loss is clinically evident and unfortunately remains irreversible. The goal of treatment is to stop the scarring process, reduce symptoms, and prevent further outbreaks of inflammation. Sometimes we can also choose to add treatments that stimulate the growth of hair not affected by this entity, to help alopecic areas to be less visible. In this case report I describe a patient in whom we achieved not only remission of LPP but also clinically visible improvement.

Keywords: lichen planopilaris, hydroxychloroquine, minoxidil.

Accepted: June 1, 2023; Published: June 7, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vidolova Brabcová N. Clinical improvement in a patient with lichen planopilaris. Dermatol. praxi. 2023;17(2):94-96. doi: 10.36290/der.2023.016.
Download citation

References

  1. Lepe K, Nassereddin A, Salazar FJ. Lichen Planopilaris. [Updated 2022 Nov 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470325/.
  2. Alessandrini A, Bruni F, Piraccini BM, Starace M. Common causes of hair loss - clinical manifestations, trichoscopy and therapy. J Eur Acad Dermatol Venereol. 2021;35(3):629-640. doi: 10.1111/jdv.17079. Epub 2021 Jan 8. PMID: 33290611. Go to original source... Go to PubMed...
  3. Svigos K, Yin L, Fried L, Lo Sicco K, Shapiro J. A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris. Am J Clin Dermatol. 2021;22(5):681-692. doi:10.1007/s40257-021-00630-7. Go to original source... Go to PubMed...
  4. Rakowska A, Slowinska M, Kowalska-Oledzka E, Warszawik O, Czuwara J, Olszewska M, et al. Trichoscopy of cicatricial alopecia. J Drugs Dermatol. 2012;11:753-758. Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.